Secondary Stock OfferingsBy The Online Investor Staff, updated Sun., Apr. 11, 9:07 PM
|This Slide: #2 of 25|
Slide #2. Amyris, Inc. — Secondary Offering
Amyris, Inc. (NASDAQ:AMRS)
Date of Pricing:
Price Per Share:
Secondary Offering Details:
Amyris, Inc. (Nasdaq: AMRS) ("Amyris"), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced the pricing of an underwritten public offering of an aggregate of 19,047,619 shares of its common stock at a public offering price of $15.75 per share, which consists of a secondary offering of 11,390,797 shares to be sold, in the aggregate, by DSM International B.V. and affiliates of Vivo Capital LLC (the selling stockholders) and 7,656,822 shares to be sold by Amyris. The selling stockholders and Amyris have granted the underwriters a 30-day option to purchase up to an additional 2,857,142 shares of Amyris common stock at the public offering price, less underwriting discounts and commissions. Of this 30-day option, up to 1,708,619 shares may be sold by the selling stockholders and up to 1,148,523 shares may be sold by Amyris. The offering is expected to close on or about April 13, 2021, subject to the satisfaction of customary closing conditions.
Amyris is an industrial biotechnology company that applies its technology platform to engineer, manufacture and sell products into the Health and Wellness, Clean Beauty, and Flavor and Fragrance markets. Co.'s technology platform enables it to engineer microbes and use them as catalysts to metabolize renewable, plant-sourced sugars into ingredients. Co. is focused on the production of Biofene®, its brand of renewable farnesene, a long-chain, branched hydrocarbon molecule that it manufactures through fermentation using engineered microbes. Co.'s farnesene derivatives are sold in various products as nutrition, health, skincare, fragrances, solvents, and fragrance ingredients.
AMRS SEC Filing Email Alerts Service
Open the AMRS Page at The Online Investor »
Strong Buy (4.00 out of 4)